NHS Logo
  • Home
  • Impact
  • About Us
    • Contact Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter

Innovation Stories

AwardInnovationPartnershipTraining Training the next generation of convergence scientists

AwardInnovationPartnershipTraining Training the next generation of convergence scientists

Published on 28th February 2019
DeviceDiagnosticInnovation Robust clinical utility of molecular phenotyping

DeviceDiagnosticInnovation Robust clinical utility of molecular phenotyping

Published on 25th February 2019
AwardInnovationTherapeutic Prostate Cancer UK awards £1.3 million to Imperial researchers

AwardInnovationTherapeutic Prostate Cancer UK awards £1.3 million to Imperial researchers

Published on 19th February 2019
InnovationTherapeutic Artificial Intelligence (AI) can predict survival of ovarian cancer patients

InnovationTherapeutic Artificial Intelligence (AI) can predict survival of ovarian cancer patients

Published on 18th February 2019
AwardInnovationPartnership Myeloma research boost with £10 million donation

AwardInnovationPartnership Myeloma research boost with £10 million donation

Published on 4th February 2019
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Appointment The UK DRI Centre for Care Research & Technology announced new leader
  • Prevention Research participation opportunity- COVCHIM02 – COVID-19 Challenge Study
  • Prevention Enhancing Dementia Care Through Innovative Home Monitoring Initiative
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre